SEI Investments
EWTX icon

SEI Investments’s Edgewise Therapeutics EWTX Stock Holding History

SEI Investments’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Sell
47,543
-1,539
-3% -$53.1K ﹤0.01% 1974
2026
Q1 		$1.55M Buy
49,082
+17,832
+57% +$514K ﹤0.01% 2133
2025
Q4 		$775K Sell
31,250
-7,845
-20% -$157K ﹤0.01% 2300
2025
Q3 		$634K Sell
39,095
-4,543
-10% -$64.4K ﹤0.01% 2138
2025
Q2 		$572K Buy
43,638
+676
+2% +$9.75K ﹤0.01% 2126
2025
Q1 		$945K Sell
42,962
-9,216
-18% -$242K ﹤0.01% 1925
2024
Q4 		$1.39M Sell
52,178
-432
-0.8% -$13.8K ﹤0.01% 1804
2024
Q3 		$1.4M Buy
+52,610
New +$1.05M ﹤0.01% 1835

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's EWTX Position: Q2 2026 in Review

SEI Investments reduced its Edgewise Therapeutics (EWTX) stake by 3.1% in Q2 2026, selling an estimated $53.1K and leaving 47,543 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

SEI Investments first reported a position in EWTX in Q3 2024 and has held it in 8 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • SEI Investments held 47,543 shares of Edgewise Therapeutics worth $1.93M as of Q2 2026.
  • SEI Investments sold 1,539 Edgewise Therapeutics shares in Q2 2026, an estimated $53.1K.
  • Edgewise Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1974 holding.
  • SEI Investments first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.